Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axogen (AXGN) Common Equity (2016 - 2025)

Axogen has reported Common Equity over the past 16 years, most recently at $128.8 million for Q4 2025.

  • Quarterly results put Common Equity at $128.8 million for Q4 2025, up 24.0% from a year ago — trailing twelve months through Dec 2025 was $128.8 million (up 24.0% YoY), and the annual figure for FY2025 was $128.8 million, up 24.0%.
  • Common Equity for Q4 2025 was $128.8 million at Axogen, up from $120.8 million in the prior quarter.
  • Over the last five years, Common Equity for AXGN hit a ceiling of $128.8 million in Q4 2025 and a floor of $93.2 million in Q1 2024.
  • Median Common Equity over the past 5 years was $102.8 million (2022), compared with a mean of $106.1 million.
  • Biggest five-year swings in Common Equity: dropped 14.33% in 2022 and later increased 24.0% in 2025.
  • Axogen's Common Equity stood at $112.6 million in 2021, then fell by 10.26% to $101.0 million in 2022, then decreased by 5.28% to $95.7 million in 2023, then rose by 8.62% to $103.9 million in 2024, then increased by 24.0% to $128.8 million in 2025.
  • The last three reported values for Common Equity were $128.8 million (Q4 2025), $120.8 million (Q3 2025), and $112.3 million (Q2 2025) per Business Quant data.